Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Undergraduate School

University of Notre Dame

2004, South Bend, IN

Medical School

Harvard Medical School

2004, Boston, MA

Internship

The Children's Hospital at University of Colorado

2005, Denver, CO

Residency

The Children's Hospital at University of Colorado

2007, Denver, CO

Fellowship

Pediatric Cardiology

Boston Children's Hospital

2010, Boston, MA

Fellowship

Chief Fellow, Pediatric Cardiology

Boston Children's Hospital

2011, Boston, MA

Fellowship

Senior Fellow, Non-Invasive Imaging

Boston Children's Hospital

2012, Boston, MA

Certifications

  • American Board of Pediatrics (Cardiology)
  • American Board of Pediatrics (General)

Professional History

I am a pediatric and fetal cardiologist at Boston Children’s Hospital with focus in non-invasive imaging at Boston Children’s Hospital. My clinical focuses are echocardiography, particularly fetal echocardiography, management of congenital heart disease, and Kawasaki Disease.

 

My research interests include diastolic function in left-sided congenital heart disease, fetal diagnosis and management of complex congenital heart disease, and Kawasaki Disease.

Media

Caregiver Profile

Meet Dr. Kevin Friedman

Publications

  1. Myocardial Infarction in Kawasaki Disease. J Pediatr. 2025 May 12; 114638. View Abstract

  2. Correction to: Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association. Circulation. 2025 Apr; 151(13):e863. View Abstract

  3. Six-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study. JAMA Pediatr. 2025 Mar 01; 179(3):293-301. View Abstract

  4. Design and rationale of the COVID vaccine-associated myocarditis/pericarditis (CAMP) study. Am Heart J. 2025 Mar; 281:32-42. View Abstract

  5. Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association. Circulation. 2024 Dec 03; 150(23):e481-e500. View Abstract

  6. Operative and nonoperative outcomes in patients with trisomy 13 and 18 with congenital heart disease. JTCVS Open. 2024 Aug; 20:123-131. View Abstract

  7. Cleft closure and other predictors of contemporary outcomes after atrioventricular canal repair in patients with parachute left atrioventricular valve. Interdiscip Cardiovasc Thorac Surg. 2024 Mar 29; 38(4). View Abstract

  8. Technical Success and Serious Adverse Events for Fetal Aortic Valvuloplasty in a Large 20-Year Cohort. JACC Adv. 2024 Mar; 3(3):100835. View Abstract

  9. Association of tetralogy of Fallot and complete atrioventricular canal: a single-centre 40-year experience. Eur J Cardiothorac Surg. 2024 Feb 01; 65(2). View Abstract

  10. Arch watch: current approaches and opportunities for improvement. J Perinatol. 2024 03; 44(3):325-332. View Abstract

  11. Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders. Arthritis Rheumatol. 2024 02; 76(2):285-292. View Abstract

  12. The Yasui operation: A single institutional experience over 30 years. JTCVS Open. 2023 Sep; 15:361-367. View Abstract

  13. Left atrioventricular valve repair after primary atrioventricular canal surgery: Predictors of durability. J Thorac Cardiovasc Surg. 2023 10; 166(4):1168-1177. View Abstract

  14. MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children. Eur J Pediatr. 2023 Jun; 182(6):2865-2872. View Abstract

  15. COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry. Pediatr Cardiol. 2023 Aug; 44(6):1373-1381. View Abstract

  16. Tachyarrhythmias During Hospitalization for COVID-19 or Multisystem Inflammatory Syndrome in Children and Adolescents. J Am Heart Assoc. 2022 10 18; 11(20):e025915. View Abstract

  17. Symmetric bicuspidizing repair for patients with congenital aortic or truncal valve disease. J Thorac Cardiovasc Surg. 2023 Aug; 166(2):283-291. View Abstract

  18. Technically successful fetal aortic valvuloplasty acutely improves left heart output. Prenat Diagn. 2022 10; 42(11):1466-1470. View Abstract

  19. Tricuspid valve repair concomitant with the Norwood operation among babies with hypoplastic left heart syndrome. Eur J Cardiothorac Surg. 2022 09 02; 62(4). View Abstract

  20. Hemodynamic and anatomic changes after fetal aortic valvuloplasty are associated with procedural success and postnatal biventricular circulation. Prenat Diagn. 2022 09; 42(10):1312-1322. View Abstract

  21. Association of Acute Anti-inflammatory Treatment With Medium-term Outcomes for Coronary Artery Aneurysms in Kawasaki Disease. CJC Pediatr Congenit Heart Dis. 2022 Aug; 1(4):174-183. View Abstract

  22. Definitive Closure of the Patent Ductus Arteriosus in Preterm Infants and Subsequent Short-Term Respiratory Outcomes. Respir Care. 2022 05; 67(5):594-606. View Abstract

  23. Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis. Eur J Pediatr. 2022 Jul; 181(7):2879-2883. View Abstract

  24. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Rheumatol. 2022 04; 74(4):586-596. View Abstract

  25. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Care Res (Hoboken). 2022 04; 74(4):538-548. View Abstract

  26. Fetal Brain Volume Predicts Neurodevelopment in Congenital Heart Disease. Circulation. 2022 04 12; 145(15):1108-1119. View Abstract

  27. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis Rheumatol. 2022 04; 74(4):e1-e20. View Abstract

  28. Longitudinal Cardiac Testing in Patients with Kawasaki Disease with No Coronary Involvement: How Much Is Too Much? J Pediatr. 2022 05; 244:10-12. View Abstract

  29. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021 12 01; 6(12):1446-1450. View Abstract

  30. Single-Leaflet Aortic Valve Reconstruction Utilizing the Ozaki Technique in Patients With Congenital Aortic Valve Disease. Semin Thorac Cardiovasc Surg. 2022; 34(4):1262-1272. View Abstract

  31. Phenotyping respiratory decompensation following definitive closure of the patent ductus arteriosus in preterm infants. J Perinatol. 2022 05; 42(5):649-654. View Abstract

  32. Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2021 10 19; 10(20):e023310. View Abstract

  33. Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A Review. Chest. 2022 03; 161(3):791-802. View Abstract

  34. Coagulation profiles and viscoelastic testing in multisystem inflammatory syndrome in children. Pediatr Blood Cancer. 2021 12; 68(12):e29355. View Abstract

  35. Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms. J Cardiovasc Comput Tomogr. 2022 Jan-Feb; 16(1):43-50. View Abstract

  36. Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms. J Pediatr. 2022 01; 240:164-170.e1. View Abstract

  37. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives. Am Heart J. 2022 01; 243:43-53. View Abstract

  38. Coronary artery aneurysms in children is not always Kawasaki disease: a case report on Takayasu arteritis. BMC Rheumatol. 2021 Aug 12; 5(1):27. View Abstract

  39. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. N Engl J Med. 2021 07 01; 385(1):23-34. View Abstract

  40. Bronchomalacia in Right Aortic Arch Treated With Descending Aortic Translocation and Airway Splint. Ann Thorac Surg. 2022 03; 113(3):e187-e189. View Abstract

  41. Reply. Arthritis Rheumatol. 2021 07; 73(7):1342-1343. View Abstract

  42. Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. Pediatr Rheumatol Online J. 2021 Mar 17; 19(1):31. View Abstract

  43. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021 03 16; 325(11):1074-1087. View Abstract

  44. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis. CJC Open. 2021 Jul; 3(7):880-887. View Abstract

  45. Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome. Pediatrics. 2021 05; 147(5). View Abstract

  46. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2. Arthritis Rheumatol. 2021 Apr; 73(4):e13-e29. View Abstract

  47. Late gestation predictors of a postnatal biventricular circulation after fetal aortic valvuloplasty. Prenat Diagn. 2021 03; 41(4):479-485. View Abstract

  48. Prenatal Diagnosis of Congenital Heart Disease the Past, Present, and Future. Current Treatment Options in Cardiovascular Medicine. 2021; 2(23):1-10.

  49. Importance of Noninvasive Cardiac Output Measurement in Children: Feasibility or Applicability? J Cardiothorac Vasc Anesth. 2021 05; 35(5):1358-1359. View Abstract

  50. Parent and Physician Understanding of Prognosis in Hospitalized Children With Advanced Heart Disease. J Am Heart Assoc. 2021 01 19; 10(2):e018488. View Abstract

  51. Comparison Between Currently Recommended Long-Term Medical Management of Coronary Artery Aneurysms After Kawasaki Disease and Actual Reported Management in the Last Two Decades. Pediatr Cardiol. 2021 Mar; 42(3):676-684. View Abstract

  52. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. J Pediatr. 2021 05; 232:127-132.e3. View Abstract

  53. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 2021 01 05; 143(1):78-88. View Abstract

  54. Difference in the prevalence of intracardiac thrombus on the first presentation of atrial fibrillation versus flutter in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2020 12; 31(12):3243-3250. View Abstract

  55. Regional Brain Growth Trajectories in Fetuses with Congenital Heart Disease. Ann Neurol. 2021 01; 89(1):143-157. View Abstract

  56. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950. View Abstract

  57. Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children: A Call to Action. J Am Coll Cardiol. 2020 10 27; 76(17):1962-1964. View Abstract

  58. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1. Arthritis Rheumatol. 2020 11; 72(11):1791-1805. View Abstract

  59. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child. 2021 03; 106(3):247-252. View Abstract

  60. Ascending Aortoplasty in Pediatric Patients Undergoing Aortic Valve Procedures. Ann Thorac Surg. 2021 09; 112(3):855-861. View Abstract

  61. UpToDate. COVID-19: Multisystem inflammatory syndrome in children (MIS-C) management and outcome. 2020.

  62. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome. Pediatrics. 2020 11; 146(5). View Abstract

  63. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021 Feb; 180(2):307-322. View Abstract

  64. Update on the Management of Kawasaki Disease. Pediatr Clin North Am. 2020 10; 67(5):811-819. View Abstract

  65. Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry. J Am Heart Assoc. 2020 08 04; 9(15):e016440. View Abstract

  66. Case Report: Hybrid Approach to Neonatal Repair of Large Symptomatic Congenital Coronary Artery Fistula. JTCVS Techniques. 2020.

  67. Hybrid approach to neonatal repair of large symptomatic congenital coronary artery fistula. JTCVS Tech. 2020 Sep; 3:295-297. View Abstract

  68. Association of Isolated Congenital Heart Disease with Fetal Brain Maturation. AJNR Am J Neuroradiol. 2020 08; 41(8):1525-1531. View Abstract

  69. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial. Can J Cardiol. 2020 10; 36(10):1598-1607. View Abstract

  70. Early Infant Symptomatic Patients With Tetralogy of Fallot With Absent Pulmonary Valve: Pulmonary Artery Management and Airway Stabilization. Ann Thorac Surg. 2020 11; 110(5):1644-1650. View Abstract

  71. Children at Risk: Multisystem Inflammatory Syndrome and COVID-19. JACC Case Rep. 2020 Jul 15; 2(9):1271-1274. View Abstract

  72. Pulmonary Valve Reconstruction Using the Ozaki Leaflet Reconstructive Techniques. Ann Thorac Surg. 2021 01; 111(1):e19-e21. View Abstract

  73. 1.5-Ventricle Repair Using Left Ventricle as the Subpulmonary Ventricle. Ann Thorac Surg. 2020 12; 110(6):e529-e530. View Abstract

  74. Apixaban for treatment of intracardiac thrombosis in children with congenital heart disease. Interact Cardiovasc Thorac Surg. 2020 06 01; 30(6):950-951. View Abstract

  75. Aortic uncrossing and tracheobronchopexy corrects tracheal compression and tracheobronchomalacia associated with circumflex aortic arch. J Thorac Cardiovasc Surg. 2020 Sep; 160(3):796-804. View Abstract

  76. Management of Myocardial Infarction in Children with Giant Coronary Artery Aneurysms after Kawasaki Disease. J Pediatr. 2020 06; 221:230-234. View Abstract

  77. Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome: A Decision Analysis. Circ Cardiovasc Qual Outcomes. 2020 04; 13(4):e006127. View Abstract

  78. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience. J Cardiovasc Electrophysiol. 2020 05; 31(5):1105-1113. View Abstract

  79. Fetal cardiac interventions: Where do we stand? Arch Cardiovasc Dis. 2020 Feb; 113(2):121-128. View Abstract

  80. Fetal cardiac intervention-Perspectives from a single center. Prenat Diagn. 2020 03; 40(4):415-423. View Abstract

  81. Echocardiographic Diagnosis of Anomalous Single Coronary Artery from the Pulmonary Artery: Use of Bubble Contrast Echocardiography. Pediatr Cardiol. 2020 Jan; 41(1):215-216. View Abstract

  82. Early-Emerging Sulcal Patterns Are Atypical in Fetuses with Congenital Heart Disease. Cereb Cortex. 2019 07 22; 29(8):3605-3616. View Abstract

  83. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease. J Pediatr. 2019 09; 212:87-92. View Abstract

  84. Current Treatment Options in Pediatrics. Acute Kawasaki Disease Therapy. 2019; [Epub ahead of print].

  85. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. J Am Heart Assoc. 2019 06 04; 8(11):e011319. View Abstract

  86. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. Pediatrics. 2019 06; 143(6). View Abstract

  87. Type B Interrupted Right Aortic Arch: Diagnostic and Surgical Approaches. Ann Thorac Surg. 2019 01; 107(1):e41-e43. View Abstract

  88. Ascending Aorta Size at Birth Predicts White Matter Microstructure in Adolescents Who Underwent Fontan Palliation. J Am Heart Assoc. 2018 12 18; 7(24):e010395. View Abstract

  89. Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease. JAMA Pediatr. 2018 12 01; 172(12):e183310. View Abstract

  90. Left Atrial Size and Function in Patients With Congenital Aortic Valve Stenosis. Am J Cardiol. 2018 11 01; 122(9):1541-1545. View Abstract

  91. Echocardiographic predictors of neonatal illness severity in fetuses with critical left heart obstruction with intact or restrictive atrial septum. Prenat Diagn. 2018 09; 38(10):788-794. View Abstract

  92. Improved technical success, postnatal outcome and refined predictors of outcome for fetal aortic valvuloplasty. Ultrasound Obstet Gynecol. 2018 08; 52(2):212-220. View Abstract

  93. Impact of a Composite Valved RV-PA Graft After Stage 1 Palliation. Ann Thorac Surg. 2018 11; 106(5):1452-1459. View Abstract

  94. Clinical and Hemodynamic Results After Conversion from Single to Biventricular Circulation After Fetal Aortic Stenosis Intervention. Am J Cardiol. 2018 08 01; 122(3):511-516. View Abstract

  95. Preoperative Physiology, Imaging, and Management of Interrupted Aortic Arch. Semin Cardiothorac Vasc Anesth. 2018 Sep; 22(3):265-269. View Abstract

  96. Early hemodynamic changes after fetal aortic stenosis valvuloplasty predict biventricular circulation at birth. Prenat Diagn. 2018 03; 38(4):286-292. View Abstract

  97. Myocardial injury in fetal aortic stenosis: Insights from amniotic fluid analysis. Prenat Diagn. 2018 02; 38(3):190-195. View Abstract

  98. Indomethacin induced ductus arteriosus closure in midgestation fetus. Clin Case Rep. 2018 03; 6(3):506-508. View Abstract

  99. Is There More to Zika? Complex Cardiac Disease in a Case of Congenital Zika Syndrome. Neonatology. 2018; 113(2):177-182. View Abstract

  100. Coronary Stenosis after Kawasaki Disease: Size Matters. J Pediatr. 2018 03; 194:8-10. View Abstract

  101. Fetal interventions for structural heart disease. Echocardiography. 2017 12; 34(12):1834-1841. View Abstract

  102. Cardiac output and blood flow redistribution in fetuses with D-loop transposition of the great arteries and intact ventricular septum: insights into pathophysiology. Ultrasound Obstet Gynecol. 2017 Nov; 50(5):612-617. View Abstract

  103. Resource reduction in pediatric chest pain: Standardized clinical assessment and management plan. Congenit Heart Dis. 2018 Jan; 13(1):46-51. View Abstract

  104. Impact of standardized clinical assessment and management plans on resource utilization and costs in children after the arterial switch operation. Congenit Heart Dis. 2017 Dec; 12(6):768-776. View Abstract

  105. Safety and Efficacy of Warfarin Therapy in Kawasaki Disease. J Pediatr. 2017 10; 189:61-65. View Abstract

  106. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population. J Am Heart Assoc. 2016 09 15; 5(9). View Abstract

  107. Cardiac Findings in the Fetus with Cerebral Arteriovenous Malformation Are Associated with Adverse Outcome. Fetal Diagn Ther. 2017; 41(2):108-114. View Abstract

  108. Systolic-diastolic functional coupling in healthy children and in those with dilated cardiomyopathy. J Appl Physiol (1985). 2016 Jun 01; 120(11):1301-18. View Abstract

  109. Needles in Hay II: Detecting Cardiac Pathology by the Pediatric Chest Pain Standardized Clinical Assessment and Management Plan. Congenit Heart Dis. 2016 Sep; 11(5):396-402. View Abstract

  110. Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease. J Am Soc Echocardiogr. 2016 Feb; 29(2):150-7. View Abstract

  111. Differentiating standardized clinical assessment and management plans from clinical practice guidelines. Acad Med. 2015 Aug; 90(8):1002. View Abstract

  112. Prevalence of Undiagnosed Structural Heart Disease in Children Undergoing Echocardiography for Kawasaki Disease. Clin Pediatr (Phila). 2016 Jun; 55(6):557-9. View Abstract

  113. Left Ventricular Remodeling and Function in Children with Biventricular Circulation After Fetal Aortic Valvuloplasty. Pediatr Cardiol. 2015 Oct; 36(7):1502-9. View Abstract

  114. Prenatal diagnosis of transposition of the great arteries over a 20-year period: improved but imperfect. Ultrasound Obstet Gynecol. 2015 Jun; 45(6):678-82. View Abstract

  115. Gathering and learning from relevant clinical data: a new framework. Acad Med. 2015 Feb; 90(2):143-8. View Abstract

  116. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients. Circulation. 2014 Aug 19; 130(8):638-45. View Abstract

  117. Perinatal and infant outcomes of prenatal diagnosis of heterotaxy syndrome (asplenia and polysplenia). Am J Cardiol. 2014 Aug 15; 114(4):612-7. View Abstract

  118. Left ventricular diastolic function and characteristics in fetal aortic stenosis. Am J Cardiol. 2014 Jul 01; 114(1):122-7. View Abstract

  119. Perinatal outcome in fetuses with heterotaxy syndrome and atrioventricular block or bradycardia. Pediatr Cardiol. 2014 Aug; 35(6):906-13. View Abstract

  120. Acute outcomes after introduction of a standardized clinical assessment and management plan (SCAMP) for balloon aortic valvuloplasty in congenital aortic stenosis. Congenit Heart Dis. 2014 Jul-Aug; 9(4):316-25. View Abstract

  121. Midgestation fetal pulmonary annulus size is predictive of outcome in tetralogy of fallot. Congenit Heart Dis. 2014 May-Jun; 9(3):187-93. View Abstract

  122. Chest pain and syncope in children: a practical approach to the diagnosis of cardiac disease. J Pediatr. 2013 Sep; 163(3):896-901.e1-3. View Abstract

  123. Standardized Clinical Assessment And Management Plans (SCAMPs) provide a better alternative to clinical practice guidelines. Health Aff (Millwood). 2013 May; 32(5):911-20. View Abstract

  124. Left ventricular diastolic function in children and young adults with congenital aortic valve disease. Am J Cardiol. 2013 Jan 15; 111(2):243-9. View Abstract

  125. Left ventricular remodeling and improvement in diastolic function after balloon aortic valvuloplasty for congenital aortic stenosis. Circ Cardiovasc Interv. 2012 Aug 01; 5(4):549-54. View Abstract

  126. Dynamic evolution of practice guidelines: analysis of deviations from assessment and management plans. Pediatrics. 2012 Jul; 130(1):93-8. View Abstract

  127. Resource Utilization Reduction for Evaluation of Chest Pain in Pediatrics Using a Novel Standardized Clinical Assessment and Management Plan (SCAMP). J Am Heart Assoc. 2012 Apr; 1(2). View Abstract

  128. Provider attitudes toward Standardized Clinical Assessment and Management Plans (SCAMPs). Congenit Heart Dis. 2011 Nov-Dec; 6(6):558-65. View Abstract

  129. Management of pediatric chest pain using a standardized assessment and management plan. Pediatrics. 2011 Aug; 128(2):239-45. View Abstract

  130. Postnatal left ventricular diastolic function after fetal aortic valvuloplasty. Am J Cardiol. 2011 Aug 15; 108(4):556-60. View Abstract

  131. Risk factors for failed staged palliation after bidirectional Glenn in infants who have undergone stage one palliation. Eur J Cardiothorac Surg. 2011 Oct; 40(4):1000-6. View Abstract

  132. A novel approach to gathering and acting on relevant clinical information: SCAMPs. Congenit Heart Dis. 2010 Jul-Aug; 5(4):343-53. View Abstract

  133. Resource utilization after introduction of a standardized clinical assessment and management plan. Congenit Heart Dis. 2010 Jul-Aug; 5(4):374-81. View Abstract

  134. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics. 2008 Oct; 122(4):e786-90. View Abstract

  135. An unusual cause of pediatric hypertension. J Pediatr. 2007 Aug; 151(2):206-12. View Abstract
BESbswy